Filing Details

Accession Number:
0001209191-21-010703
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-02-16 16:15:11
Reporting Period:
2021-02-11
Accepted Time:
2021-02-16 16:15:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1661567 Michael Parini C/O Vertex Pharmaceuticals Incorporated
50 Northern Avenue
Boston MA 02210
Evp, Chief Adm, Leg & Bd Off No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-02-11 3,818 $210.43 50,846 No 4 S Direct
Common Stock Disposition 2021-02-11 300 $211.21 50,546 No 4 S Direct
Common Stock Disposition 2021-02-11 200 $211.97 50,346 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1.
  2. Open market sales reported on this line occurred at a weighted average price of $210.43 (range $209.95 to $210.94).
  3. Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
  4. Open market sales reported on this line occurred at a weighted average price of $211.21 (range $210.97 to $211.33).
  5. Open market sales reported on this line occurred at a weighted average price of $211.97 (range $211.97 to $211.98).